Advertisement
Singapore markets closed
  • Straits Times Index

    3,231.38
    -20.33 (-0.63%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Bitcoin USD

    70,861.59
    +1,211.37 (+1.74%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,956.10
    +24.12 (+0.30%)
     
  • Gold

    2,195.10
    +4.50 (+0.21%)
     
  • Crude Oil

    81.85
    +0.50 (+0.61%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,264.80
    -45.29 (-0.62%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

This Popular Stock Has a 93% Upside, According to Wall Street

This Popular Stock Has a 93% Upside, According to Wall Street

If you had invested in Novavax (NASDAQ: NVAX) at the beginning of 2020, you'd be sitting pretty right now. Novavax's efforts to develop and market a vaccine for COVID-19 explain the company's terrific performance of late. The company's average price target of $264.20 implies gains of 93% from its share price of $136.86 as of this writing.